As matchmakers to the biopharmaceutical industry, we accelerate the generation of strategic value from the development, licensing, uptake and application of new therapeutics and enabling technologies. Our experience across the industry life-cycle underpins our unique capacity to bridge ‘the chasm’ between technology and business, scientist and entrepreneur, vendor and customer.

Industry Challenges

The industry’s ceaseless barrage of new technologies and products sees innovators, investors, suppliers and consumers wrestling to understand, evaluate or apply them. Innovators may struggle to articulate their value and demonstrate proof of concept in a seemingly vast marketplace, while potential adopters and consumers struggle to pick out the tiny sparks of innovation against its bright lights.

Amongst this throng, investors must grapple with unfamiliar terms and technologies to evaluate their potential worth. All of these players/stakeholders need active translators and doers to streamline the cycle, and this is what we do. We also see that identification of potential is only the first step to extracting value: proof of concept, targeted placement, and effective selections followed by successful deals and implementations all have to follow; so we do those too.


Our Partners all have a minimum of 20 years’ biopharmaceutical industry experience, with specialties in discovery, clinical, commercial and technology development, licensing and executive management, working for or with the majority of leading companies in the industry.

Our Clients include global pharmaceutical companies approaching major decisions, biotechs seeking development alliances, technology start-ups seeking partners, ICT vendors addressing the sector, and others who have challenging business problems in biopharmaceutical R&D.

Our Services include:

• Accelerated Market Penetration
• Discovery and Clinical IM Strategy
• Technology Sourcing & Selection
• Commercial Development & Licensing
• Operational and Change Management
• Visual Business Design^TM
• Research Reports